These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2357893)

  • 1. Angiotensin-converting enzyme inhibitors.
    Herlihy BL; Herlihy JT
    Crit Care Nurse; 1990 Mar; 10(3):74-7. PubMed ID: 2357893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 3. Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure?
    Ogihara T; Rakugi H
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):184-5. PubMed ID: 18957391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].
    Drexler H
    Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical pharmacology of angiotensin II antagonists].
    Arabidze GG; Novikova LS
    Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].
    van Vlies B
    Ned Tijdschr Geneeskd; 1992 Sep; 136(37):1796-8. PubMed ID: 1407135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with ACE inhibitors until the end of life? Cardiovascular protective mechanisms during blockade of the renin-angiotensin system].
    Werner N; Böhm M
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1513-8. PubMed ID: 15227593
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ
    Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal effects of angiotensin-I converting enzyme inhibitors.
    Gans RO; Hoorntje SJ; Donker AJ
    Neth J Med; 1988 Jun; 32(5-6):247-64. PubMed ID: 3292962
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.
    Dzau VJ; Creager MA
    Cardiol Clin; 1989 Feb; 7(1):119-30. PubMed ID: 2650868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct renin inhibition: a new and promising treatment principle in heart failure?].
    Mahfoud F; Ukena C; Böhm M
    Dtsch Med Wochenschr; 2009 Apr; 134(15):759-62. PubMed ID: 19340755
    [No Abstract]   [Full Text] [Related]  

  • 17. [The renin-angiotensin system:implications, pathology, therapeutic possibilities, perspectives].
    Ionescu SD; Sandru V; Burdujan A; Tovarniţchi S
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):669-73. PubMed ID: 12092217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual renin-angiotensin system blockade in heart failure.
    McMurray JJ; Granger CB; Ostergren J; Yusuf S; Pfeffer MA; Swedberg K
    J Am Coll Cardiol; 2009 Jul; 54(3):278; author reply 279-80. PubMed ID: 19589444
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiopathologic bases for the use of angiotensin converting enzyme inhibitors in congestive heart failure].
    Campa PP
    Cardiologia; 1986 Oct; 31(10):833-6. PubMed ID: 3028628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.